Bristow, Linda

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience

Neuroscience and Neuropharmacology ResearchNicotinic Acetylcholine Receptors Study

Cited by 944

Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists

Caine, S. B., Negus, S. S., Mello, N. K., Patel, S., Bristow, L., Kulagowski, J., Vallone, D., Saiardi, A., & Borrelli, E. (2002) · The Journal of Neuroscience

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 234

Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects

Chowdhury, G. M. I., Zhang, J., Thomas, M., Banasr, M., Ma, X., Pittman, B., Bristow, L., Schaeffer, E., Duman, R. S., Rothman, D. L., et al. (2017) · Molecular Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 197

TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates

Atack, J. R., Wafford, K. A., Tye, S. J., Cook, S. M., Sohal, B., Pike, A., Sur, C., Melillo, D., Bristow, L., Bromidge, F., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics

Neuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects

Cited by 188

Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/γ-aminobutyric acid-A receptor agonists

Guscott, M. R., Cook, G. P., & Bristow, L. J. (2000) · Behavioural Pharmacology

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 33

The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia

Bristow, L. J., Easton, A. E., Li, Y.-W., Sivarao, D. V., Lidge, R., Jones, K. M., Post-Munson, D., Daly, C., Lodge, N. J., Gallagher, L., et al. (2016) · PLOS ONE

Nicotinic Acetylcholine Receptors StudySchizophrenia research and treatment

Cited by 30

Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning

Weed, M. R., Polino, J., Signor, L., Bookbinder, M., Keavy, D., Benitex, Y., Morgan, D. G., King, D., Macor, J. E., Zaczek, R., et al. (2017) · PLOS ONE

Nicotinic Acetylcholine Receptors StudyCholinesterase and Neurodegenerative Diseases

Cited by 13